Hong Kong disclosed interests of LAV Asset Management (Hong Kong) Limited
LAV Asset Management (Hong Kong) Limited disclosed that they had the following interests in companies listed on the Hong Kong Stock Exchange.
This shows only the most recent 20 events. If you need more, or any other historical declarations by LAV Asset Management (Hong Kong) Limited, please get in touch.
| Company | Share type | Long position (%) | Date |
|---|---|---|---|
| Abbisko Cayman Ltd. | Ordinary Shares | 10.0 | 16 April 2024 |
| Abbisko Cayman Ltd. | Ordinary Shares | 9.6 | 05 December 2023 |
| ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B | H Shares | 12.2 | 05 September 2023 |
| Beijing Airdoc Technology Co., Ltd. - B | Ordinary Shares | 4.9 | 04 July 2023 |
| Innovent Biologics, Inc. | Ordinary Shares | 5.0 | 08 March 2023 |
| Transcenta Holding Ltd. | Ordinary Shares | 16.9 | 02 December 2022 |
| MicroTech Medical (Hangzhou) Co., Ltd. - B | H Shares | 7.3 | 18 November 2022 |
| CanSino Biologics Inc. - B | Ordinary Shares | 0 | 24 May 2022 |
| Transcenta Holding Ltd. | Ordinary Shares | 15.8 | 18 May 2022 |
| Peijia Medical Ltd. | Ordinary Shares | 7.1 | 18 May 2022 |
| Jacobio Pharmaceuticals Group Co., Ltd. | Ordinary Shares | 7.9 | 18 May 2022 |
| CanSino Biologics Inc. - B | Ordinary Shares | 7.1 | 18 May 2022 |
| Beijing Airdoc Technology Co., Ltd. - B | Ordinary Shares | 10.1 | 18 May 2022 |
| Abbisko Cayman Ltd. | Ordinary Shares | 10.7 | 18 May 2022 |